Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
4.930
-0.040 (-0.80%)
May 28, 2026, 3:00 PM CST

SHA:600713 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,4537,1476,4946,3426,7095,114
Market Cap Growth
-1.43%10.05%2.41%-5.47%31.18%10.34%
Enterprise Value
14,59918,87317,41518,81816,76614,628
Last Close Price
4.935.464.804.514.654.35
PE Ratio
11.9011.4411.3810.9811.2610.12
Forward PE
-27.4227.4227.4227.4227.42
PS Ratio
0.120.130.120.120.130.11
PB Ratio
0.760.870.830.871.000.98
P/TBV Ratio
0.911.030.991.031.181.20
P/FCF Ratio
--4.083.63-13.15
P/OCF Ratio
-77.843.043.33-7.36
EV/Sales Ratio
0.270.340.320.350.330.32
EV/EBITDA Ratio
9.0812.6310.3011.3810.8710.10
EV/EBIT Ratio
10.7814.0011.3312.5512.0711.25
EV/FCF Ratio
-8.32-10.9510.76-37.63
Debt / Equity Ratio
1.101.141.311.261.831.89
Debt / EBITDA Ratio
5.765.845.655.157.416.40
Debt / FCF Ratio
--6.415.21-25.38
Net Debt / Equity Ratio
0.830.740.720.931.481.49
Net Debt / EBITDA Ratio
4.704.093.334.086.415.37
Net Debt / FCF Ratio
-4.01-38.303.543.85-11.8119.99
Asset Turnover
1.581.771.821.791.751.83
Inventory Turnover
7.657.828.338.689.129.83
Quick Ratio
1.081.061.161.000.970.99
Current Ratio
1.451.531.631.401.311.34
Return on Equity (ROE)
10.06%10.38%9.88%10.22%12.00%12.15%
Return on Assets (ROA)
2.46%2.71%3.25%3.12%3.02%3.30%
Return on Invested Capital (ROIC)
6.46%6.98%8.31%7.15%7.42%7.57%
Return on Capital Employed (ROCE)
10.40%10.40%11.30%15.20%14.80%15.60%
Earnings Yield
9.64%8.74%8.79%9.11%8.88%9.88%
FCF Yield
-27.20%-2.23%24.50%27.57%-12.48%7.60%
Dividend Yield
3.42%3.11%3.54%3.55%3.01%2.76%
Payout Ratio
73.50%78.84%88.47%101.75%81.07%185.06%
Buyback Yield / Dilution
-14.84%-12.58%-0.33%-3.54%-20.39%0.10%
Total Shareholder Return
-11.46%-9.47%3.21%0.00%-17.39%2.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.